Olema Pharmaceuticals, Inc.

NASDAQ:OLMA

12.7 (USD) • At close September 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -96.655-104.787-71.096-22.121-4.316-2.197
Depreciation & Amortization 0.3770.3570.1630.0110.0090.008
Deferred Income Tax -2.32400.276000
Stock Based Compensation 17.25618.82915.9133.10800.001
Change In Working Capital -0.5893.0222.83-1.5051.226-0.11
Accounts Receivables 000000
Inventory 000000
Accounts Payables 2.3240.351-0.683-0.221.168-0.1
Other Working Capital -2.9132.6713.513-1.2850.058-0.01
Other Non Cash Items -1.7920.5141.2240.641-1.150.122
Operating Cash Flow -83.727-82.065-50.69-19.866-3.081-2.176
Investing Activities:
Investments In Property Plant And Equipment 0-0.363-1.575-0.05600
Acquisitions Net 00.3631.575000
Purchases Of Investments -255.625-213.66-486.967000
Sales Maturities Of Investments 250.76305.502213.104000
Other Investing Activites 0.014-0.363-1.575-0.05600
Investing Cash Flow -4.85191.479-275.438-0.05600
Financing Activities:
Debt Repayment 000-3.0880-0.323
Common Stock Issued 133.4150.330.721220.5505.254
Common Stock Repurchased 000-2.28900
Dividends Paid 000000
Other Financing Activities 132.3650.1460.67143.2305.254
Financing Cash Flow 133.4150.4761.391358.40305.254
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash 44.8379.89-324.737338.481-3.0813.078
Cash At End Of Period 68.53923.70213.812338.5490.0683.149